⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 18, 2025Diabetes TherapyOpen Access

Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion

Christopher Jacobson Kevin B. Kaiserman Johanna Ulloa Jennifer Pleitez Joseph Sylvan Joanne Rinker Kevin Codorniz Scott Lee Mehrbod Vakhshoori Pamela Lobo Moreno Thomas Blevins

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

ClinicalTrials.gov NCT05243628.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jacobson et al. (2025) studied this question.

synapsesocial.com/papers/69d855c15c3030ff03d19f24 https://doi.org/10.1007/s13300-025-01760-5

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rethinking the Viability and Utility of Inhaled Insulin in Clinical PracticeReview · 2018 · 48 citations
2Insulin delivery methods: Past, present and futureReview · 2016 · 289 citations
3Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian PerspectivePrognostic Study · 2019 · 41 citations
4Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled InsulinOriginal Research · 2016 · 84 citations
5Ultrafast-Acting Insulins: State of the ArtReview · 2012 · 89 citations

Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus2020
Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus2021
Technosphere® Insulin: Defining the Role of Technosphere Particles at the Cellular Level2009
A Malaysian Expert Consensus on The Identification, Evaluation, and Pharmacological Management of Diabetic Sensorimotor PolyneuropathyDiabetes Therapy · 2026
Clinical Performance of the IWGDF Risk Stratification System for Diabetic Foot Ulceration: A Gender-Disaggregated Study of 713 PatientsDiabetes Therapy · 2026

More from Diabetes Therapy

More from Loma Linda University

More from Loma Linda University Medical Center

More from MannKind Corporation (United States)

More from Texas Diabetes & Endocrinology